ARTICLE | Company News
ObsEva deal
December 7, 2015 8:00 AM UTC
Kissei granted ObsEva exclusive, ex-Asian rights to develop and commercialize KLH-2109. The companies will collaborate on development of the gonadotropin-releasing hormone (GnRH) antagonist, which wi...